Akadeum Life Sciences

Akadeum Life Sciences primarily addresses long-standing sample preparation issues in the research, diagnostics, and cell therapy markets by employing a novel floating-target separation platform technology. Without this crucial step of separation (isolating biological targets such as DNA, proteins, or cells from biological samples), many diagnostics and treatments would not be possible. More than solving a single issue, this elegantly simple platform technology is revolutionizing the separation market—from nucleic acid extraction to cell isolation. The company is the first to commercialize buoyancy-activated cell sorting (BACS™) microbubble kits for cell separation applications. At the same time, the company is also building industry partnerships.